Elisabeth Groß

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Long Noncoding Rna

Metastatic Colorectal Cancer

Reduced Graphene Oxide

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabeth Groß, Ralf-Axel Hilger, Franziska Lea Schümann, Marcus Bauer, Alyssa Bouska, Christian Rohde, Edith Willscher, Jana Lützkendorf, Lutz Peter Müller, Bayram Edemir, Thomas Mueller, Marco Herling, Mascha Binder, Claudia Wickenhauser, Javeed Iqbal, Guido Posern, Thomas Weber
SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters. Cancers 15 (11) (2023)
Sebastian W Schleser, Oleksandr Krytovych, Tim Ziegelmeier, Elisabeth Groß, Jana Kasparkova, Viktor Brabec, Thomas Weber, Rainer Schobert, Thomas Mueller
Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells. Molecules (Basel, Switzerland) 28 (13) (2023)
Kathleen Gebhardt, Bayram Edemir, Elisabeth Groß, Linda Nemetschke, Stefanie Kewitz-Hempel, Rose K C Moritz, Cord Sunderkoetter, Dennis Gerloff
BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma. Cancers 13 (10) (2021)
Franziska Lea Schümann, Marcus Bauer, Elisabeth Groß, Denis Terziev, Andreas Wienke, Claudia Wickenhauser, Mascha Binder, Thomas Weber
RBMX Protein Expression in T-Cell Lymphomas Predicts Chemotherapy Response and Prognosis. Cancers 13 (19) (2021)
Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer, Christian Rohde, Sarah Sandmann, Denis Terziev, Lutz P Müller, Guido Posern, Andreas Wienke, Falko Fend, Martin-Leo Hansmann, Wolfram Klapper, Andreas Rosenwald, Harald Stein, Martin Dugas, Carsten Müller-Tidow, Claudia Wickenhauser, Mascha Binder, Thomas Weber
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas. Biomedicines 9 (12) (2021)